ReviewAnnals of translational medicine2020

Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option.

Shanthi Sabarimurugan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.